Joshua L Gowin1, April C May2, Marc Wittmann3, Susan F Tapert4, Martin P Paulus5. 1. Psychiatry, University of California San Diego, La Jolla, CA; Section on Human Psychopharmacology, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD. 2. Psychiatry, University of California San Diego, La Jolla, CA. 3. Psychiatry, University of California San Diego, La Jolla, CA; Empirical and Analytical Psychophysics, Institute for Frontier Areas of Psychology and Mental Health, Freiburg, Germany. 4. Psychiatry, University of California San Diego, La Jolla, CA; Psychology Service, VA San Diego Healthcare System, La Jolla, CA. 5. Psychiatry, University of California San Diego, La Jolla, CA; Psychiatry Service, VA San Diego Healthcare System, La Jolla, CA; Laureate Institute for Brain Research, Tulsa, OK.
Abstract
BACKGROUND: Cocaine use disorders (CUDs) have been associated with increased risk-taking behavior. Neuroimaging studies have suggested that altered activity in reward and decision-making circuitry may underlie cocaine user's heightened risk-taking. It remains unclear if this behavior is driven by greater reward salience, lack of appreciation of danger, or another deficit in risk-related processing. METHODS: Twenty-nine CUD participants and forty healthy comparison participants completed the Risky Gains Task during a functional magnetic resonance imaging scan. During the Risky Gains Task, participants choose between a safe option for a small, guaranteed monetary reward and risky options with larger rewards but also the chance to lose money. Frequency of risky choice overall and following a win versus a loss were compared. Neural activity during the decision and outcome phase were examined using linear mixed effects models. RESULTS: Although the groups did not differ in overall risk-taking frequency, the CUD group chose a risky option more often following a loss. Neuroimaging analyses revealed that the comparison group showed increasing activity in the bilateral ventral striatum as they chose higher-value, risky options, but the CUD group failed to show this increase. During the outcome phase, the CUD group showed a greater decrease in bilateral striatal activity relative to the comparison group when losing the large amount, and this response was correlated with risk-taking frequency after a loss. CONCLUSIONS: The brains of CUD individuals are hypersensitive to losses, leading to increased risk-taking behaviors, and this may help explain why these individuals take drugs despite aversive outcomes.
BACKGROUND:Cocaine use disorders (CUDs) have been associated with increased risk-taking behavior. Neuroimaging studies have suggested that altered activity in reward and decision-making circuitry may underlie cocaine user's heightened risk-taking. It remains unclear if this behavior is driven by greater reward salience, lack of appreciation of danger, or another deficit in risk-related processing. METHODS: Twenty-nine CUD participants and forty healthy comparison participants completed the Risky Gains Task during a functional magnetic resonance imaging scan. During the Risky Gains Task, participants choose between a safe option for a small, guaranteed monetary reward and risky options with larger rewards but also the chance to lose money. Frequency of risky choice overall and following a win versus a loss were compared. Neural activity during the decision and outcome phase were examined using linear mixed effects models. RESULTS: Although the groups did not differ in overall risk-taking frequency, the CUD group chose a risky option more often following a loss. Neuroimaging analyses revealed that the comparison group showed increasing activity in the bilateral ventral striatum as they chose higher-value, risky options, but the CUD group failed to show this increase. During the outcome phase, the CUD group showed a greater decrease in bilateral striatal activity relative to the comparison group when losing the large amount, and this response was correlated with risk-taking frequency after a loss. CONCLUSIONS: The brains of CUD individuals are hypersensitive to losses, leading to increased risk-taking behaviors, and this may help explain why these individuals take drugs despite aversive outcomes.
Authors: C W Lejuez; Jennifer P Read; Christopher W Kahler; Jerry B Richards; Susan E Ramsey; Gregory L Stuart; David R Strong; Richard A Brown Journal: J Exp Psychol Appl Date: 2002-06
Authors: Karen D Ersche; Anna Barnes; P Simon Jones; Sharon Morein-Zamir; Trevor W Robbins; Edward T Bullmore Journal: Brain Date: 2011-06-20 Impact factor: 13.501
Authors: Ranjita Poudel; Michael C Riedel; Taylor Salo; Jessica S Flannery; Lauren D Hill-Bowen; Simon B Eickhoff; Angela R Laird; Matthew T Sutherland Journal: Drug Alcohol Depend Date: 2020-02-04 Impact factor: 4.492
Authors: Ryan P Bell; Sheri L Towe; Zahra Lalee; Scott A Huettel; Christina S Meade Journal: Cogn Affect Behav Neurosci Date: 2020-08 Impact factor: 3.282
Authors: Emma C Lathan; Judy H Hong; Angela M Heads; Nicholas C Borgogna; Joy M Schmitz Journal: Subst Use Misuse Date: 2021-09-24 Impact factor: 2.362
Authors: Caitlin A Orsini; Shelby L Blaes; Richard J Dragone; Sara M Betzhold; Alyssa M Finner; Jennifer L Bizon; Barry Setlow Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2019-10-30 Impact factor: 5.067
Authors: Trevor Steward; Asier Juaneda-Seguí; Gemma Mestre-Bach; Ignacio Martínez-Zalacaín; Nuria Vilarrasa; Susana Jiménez-Murcia; Jose A Fernández-Formoso; Misericordia Veciana de Las Heras; Nuria Custal; Nuria Virgili; Rafael Lopez-Urdiales; Amador García-Ruiz-de-Gordejuela; José M Menchón; Carles Soriano-Mas; Fernando Fernandez-Aranda Journal: J Clin Med Date: 2019-09-27 Impact factor: 4.241